Form D · Pharmaceuticals
Design Therapeutics, Inc.
Carlsbad, CA · CIK 0001807120
Offering snapshot reported Feb 12, 2021 · SEC filing
- Reported sold
- $125M Offering amount: $125M
- Investors reported
- 26 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jan 25, 2021 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 12, 2021 | Initial | $125,000,063 | No comparison | 26 | SEC filing |
| Jun 3, 2020 | Amendment | $45,500,246 | $0vs Mar 20, 2020 | 6 | SEC filing |
| Mar 20, 2020 | Initial | $45,500,246 | No comparison | 6 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-389403
Source: Form D, filed Feb 12, 2021. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Aseem Z. Ansari, Ph.D. | Director |
| Simeon George, M.D. | Director |
| Sean Jeffries, Ph.D. | Executive |
| Rodney Lappe, Ph.D. | Director |
| John Schmid | Director |
| Pratik Shah, Ph.D. | Director, Executive |
| Joao Siffert, M.D. | Director, Executive |
| Arsani William, M.D. | Director |
| Stella Xu, Ph.D. | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
6005 Hidden Valley Road, Suite 110
Carlsbad, CA, 92011
Carlsbad, CA, 92011